VALUE OF BIOCHEMICAL URINARY MARKERS IN DIAGNOSIS AND PROGNOSIS OF BLADDER CANCER PATIENTS

Evaluation of Minichromosome Maintenance Deficient-5 Levels in non-Muscle invasive Bladder Cancer Patients

Evaluation of Serum Bladder Cancer Specific Nuclear Matrix Proteins - 1 levels in Non-Muscle Invasive Bladder Cancer Patients.

Evaluation of IGF-2 Gene Expression in Urine and its Potential Use as Biomarker for Bladder Cancer

Evaluation of Neoadjuvant Chemotherapy in Treatment of Muscle Invasive Urothelial Bladder Tumors in Upper Egypt

Bladder Cancer Molecular Classification: Current Status and Future Prospects.

Review Article: Prognostic Value of CK5/6 Expression in Urinary Bladder Carcinoma

Prognostic role of CHEK2, FASN and Her2/neu Expression in Stage Ta-T1 Non-Muscle-Invasive Bladder Cancer (NMIBC)

Telomerase Reverse Transcriptase and miR-34a in diagnosis of non-muscle invasive bladder cancer

Clinical importance of P53 and P21 determination as a biomarkers in bladder cancer and bilharzial patients